+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Non Small Cell Lung Cancer Drug"

From
Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024 - Product Thumbnail Image

Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024

  • Clinical Trials
  • February 2024
  • 180 Pages
  • Global
From
From
Global Non-small Cell Lung Cancer Drugs Market 2023-2027 - Product Thumbnail Image

Global Non-small Cell Lung Cancer Drugs Market 2023-2027

  • Report
  • May 2023
  • 167 Pages
  • Global
From
From
From
From
From
Lung Cancer Therapeutics: Global Markets - Product Thumbnail Image

Lung Cancer Therapeutics: Global Markets

  • Report
  • November 2018
  • 161 Pages
  • Global
From
C-Met Mutated Non-small Cell Lung Cancer (NSCLC) - Pipeline Insight, 2021 - Product Thumbnail Image

C-Met Mutated Non-small Cell Lung Cancer (NSCLC) - Pipeline Insight, 2021

  • Clinical Trials
  • February 2021
  • 60 Pages
  • Global
From
Non-Small Cell Lung Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
HER2+ Non Small Cell Lung Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

HER2+ Non Small Cell Lung Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Non Small Cell Lung Cancer Drug market is a subset of the larger Lung Cancer Drug market. Non Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all lung cancer cases. NSCLC is typically treated with chemotherapy, radiation, and targeted therapies. Targeted therapies are drugs that target specific molecules involved in the growth and spread of cancer cells. These drugs are designed to block the growth and spread of cancer cells while limiting damage to healthy cells. The Non Small Cell Lung Cancer Drug market is highly competitive, with a number of companies offering various treatments. Companies such as AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, and Pfizer are some of the major players in the market. Other companies such as Amgen, Boehringer Ingelheim, and Novartis are also active in the market. Show Less Read more